ClinicalTrials.Veeva

Menu

Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)

R

Rapid Medical

Status

Completed

Conditions

Intracranial Aneurysm

Treatments

Device: Comaneci Embolization Assist Device

Study type

Observational

Funder types

Industry

Identifiers

NCT04518670
CLN-Co-001

Details and patient eligibility

About

The Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the neck width as ≥ 4 mm or a dome-to-neck ratio < 2.

The objective of the Postmarket Surveillance Plan is to assess safety and performance as used in postmarket clinical practice in the U.S.

Enrollment

90 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient has a documented intracranial ruptured or unruptured aneurysm, suitable for embolization by coils.
  2. Patient is considered for treatment with coil embolization assisted by the Comaneci Device for wide-necked intracranial aneurysms with neck width ≤ 10 mm. A wide-necked intracranial aneurysm is defined by the neck width as ≥ 4 mm or a dome-to-neck ratio < 2.
  3. A signed informed consent by the patient or legally authorized representative

Exclusion criteria

1. Patient with known hypersensitivity to nickel-titanium

Trial design

Trial documents
1

Trial contacts and locations

8

Loading...

Central trial contact

Walid Haddad, Dr.; ‪Neta Maymon‬, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems